openPR Logo
Press release

Post herpetic Neuralgia Treatment Market is Expecting Worldwide Growth by 2017 – 2025

08-03-2017 02:02 PM CET | Health & Medicine

Press release from: Persistence Market Research

Post herpetic Neuralgia Treatment Market is Expecting

Acute pain is caused due to an attack on shingles by varicella zoster virus, which usually stops when the shingles rash is cleared and it continues after cure this situation is named as post-herpetic neuralgia (PHN). The condition is more prone in the people with the age more than 70 years. Furthermore, the pain is either regular or non–continuous and is typically painful. Allodynia is a condition refers to the cessation of pain by any stimulus without pain, which is often a stressful feature of PHN. Sleep disturbance and clinical depression are common in this condition. PNH is a commonly occurring condition and frequently encountered in the clinics and various other diagnostic centers globally. According to Journal of the Japan Medical Association, it has been reported that the number of patients is 140–180 per 100,000 population and around 20% of the population suffers from PNH at any age during the lifespan. In Japan, around 500,000 people were affected by herpes zoster in a year.

Another view advocates that neuralgia following herpes zoster should be collectively considered post herpetic pain (PHP), in which PHN is only one constituent. This view regards PHN as “differentiation pain due degeneration of the nerves. According to this theory, transition to PHN is presumed to occur about one month after the onset of herpes zoster and to persist thereafter. However, in many cases of herpes zoster, neuralgia as a form of PHP may be present for 2–3 months after the successful treatment of eruptions, and therefore, it is difficult to form a clear distinction between PHP and PHN.

Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/14506

Drugs which have a direct effect on the nervous system are the most helpful. Drugs used to treat depression can be effective against the nerve pain of post herpetic neuralgia. Antidepressants such as amitriptyline or nor-triptyline must be taken regularly for benefiting the improvement in the condition. Specific problem in patients whose pain remains as post herpetic neuralgia reduced quality of life, which includes correlation between increasing in severity of pain along with the extent of post herpetic neuralgia negative impact on life quality. Furthermore, pain interferes with general activity such as sleep and mood, more severe pain leads to symptoms of anxiety and depression. Instruments involved in health-related quality of life consists four key health domains such as physical, psychological, social, and functional. Both herpes zoster and post herpetic neuralgia have effects on patient life across all the health domains.

Unfortunately, there are currently no absolute prophylaxis for post herpetic neuralgia. However, since post herpetic neuralgia occurs as a sequel to herpes zoster, the prevention of herpes zoster can be useful. In dosage therapy types of antiviral drugs the renal function is considered as an important issue. Dose adjustment strictly necessary for geriatric population along with people with any renal disorder. Furthermore, the dosage regimens of parenteral formulations are described in detail by instructions given by the manufacturer of such dosage forms of the respective drugs, and the treatment of patients should follow the given instructions. In case of renal dysfunction, the dose of the drug is determined as per serum creatinine clearance. Practically, the serum creatinine clearance can be obtained by analyzing serum creatinine level with body weight and age of the patient in terms of a derived formula.

Revenue growth in the post herpetic neuralgia treatment is expected to gain traction in the near future owing to favorable environmental cues in the market such as rise in prevalence of disease caused due to herpes virus. Taking in account all options for treating post herpetic neuralgia are neglected available at different levels is the major factor hindering the market.

Global post herpetic neuralgia treatment market is segmented on the basis of drug type and distribution channel

Segmentation by Drug Type
Gabapentin
Pregabalin
Capsaicin
Lidocaine Plasters
Tramadol
Opioids
Others
Segmentation by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Various antiviral drugs for the treatment of post herpetic disorder have been developed and are being used widely in clinical practice currently, although the efficacy few antiviral agents have been denied for post herpetic neuralgia. However, methods of handling patients and the antiviral agent usage in a clinical setting should be taken into account further considering both the prediction and prevention of the onset of herpes zoster and post herpetic neuralgia. Also various topical agents are being approved to cure post herpetic neuralgia, agents such as lidocaine patch applied with a local anesthetic. The treatment can cause local irritation but it is relatively benign in nature. Lidocaine also comes in ointment or cream form in a variety of strengths.

By region, post herpetic neuralgia treatment market is segmented into five regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America dominates the global post herpetic neuralgia treatment market due to rise in awareness of the disorder and introduction of novel drugs.

Some of the player in the post herpetic neuralgia treatment market are Endo Pharmaceuticals Inc., Depomed, Inc., Acorda Therapeutics.

To view complete report @ http://www.persistencemarketresearch.com/market-research/post-herpetic-neuralgia-treatment-market.asp

About Us 
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
 PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Post herpetic Neuralgia Treatment Market is Expecting Worldwide Growth by 2017 – 2025 here

News-ID: 654669 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for PHN

Postherpetic Neuralgia (PHN) Market: Major Trends Reshaping the Future of the In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Postherpetic Neuralgia (PHN) Industry Market Size Be by 2025? The market for postherpetic neuralgia (phn) has witnessed significant growth lately. The market, which was worth $0.72 billion in 2024, is projected to increase to $0.77 billion by 2025, showcasing a compound annual growth rate (CAGR) of
Post Herpetic Neuralgia Treatment Market Projected to Hit USD 4.05 Billion by 20 …
𝐏𝐨𝐬𝐭 𝐇𝐞𝐫𝐩𝐞𝐭𝐢𝐜 𝐍𝐞𝐮𝐫𝐚𝐥𝐠𝐢𝐚 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 is expected to grow at a CAGR of 3.2% during the forecast period. Post Herpetic Neuralgia Treatment Market is expected to reach US$ 4.05 Bn. by 2030. 𝐏𝐨𝐬𝐭 𝐇𝐞𝐫𝐩𝐞𝐭𝐢𝐜 𝐍𝐞𝐮𝐫𝐚𝐥𝐠𝐢𝐚 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰: The Post Herpetic Neuralgia (PHN) Treatment market is poised for significant growth, driven by the increasing prevalence of herpes zoster (shingles) and the associated risk of PHN among aging populations worldwide. PHN is a
Respiratory Clinics Market 2022 Global Demand and Emerging Trends by 2030- Adela …
Global Respiratory Clinics Market Report is a meticulously undertaken study. Experts with proven credentials and a high standing within the research fraternity have presented an in-depth analysis of the subject matter, bringing to bear their unparalleled domain knowledge and vast research experience. They offer some penetrating insights into the complex world of Respiratory Clinics Market Industry. Their sweeping overview, comprehensive analyses, precise definitions, clear classifications, and expert opinions on applications,
Present and Future Scenario of Global Respiratory Clinics Market Report 2021-203 …
In the United States currently more than 25 million people are diagnosed with asthma, because of these respiratory diseases there is a burden on annual healthcare expenditures for treatment of respiratory diseases. The increase in number of respiratory clinics will surely expand the treatment of respiratory diseases even to the remotest regions. Request for Sample Copy of This Report@ https://www.absolutemarketsinsights.com/request_sample.php?id=740 Due to covid-19 pandemic the number of respiratory clinics has risen,
GervanoRA Announced the Release of Opportunity Assessment Report Titled “Posth …
GervanoRA Data Services (GDS), a premier provider of market research analysis and services based in Goa, India has announced the release of their latest report on Postherpetic Neuralgia (PHN) Pipeline Drugs – Opportunity Assessments, Epidemiology Forecast, Market Dynamics, and Pipeline Analysis H2 2018. GervanoRA’s pipeline analysis and opportunity assessment report “Postherpetic Neuralgia (PHN): Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis, H2 2018” analyzed and assessed Postherpetic Neuralgia (PHN) pipeline
Herpetic Neuralgia Treatment Market 2026 | Pfizer Inc., Mylan N.V., Teva Pharmac …
Rising incidences of post herpetic neuralgia therapy are growing the number of forwarding to pain management clinics ensuing in an expansion of the market. The worldwide market for post herpetic neuralgia treatment is likely to hold more than US$ 909 Million, in value terms, before the end of 2026, registering a CAGR of 5.4%. The players penetrating in the market are centering on arising novel drugs. There is an absence of